Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Haifeng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8181-7893; OpenAlex author ID A5100456785. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

  1. β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway. Co-author DOI 10.1007/s10735-022-10076-8↗
  2. Albendazole suppresses cell proliferation and migration and induces apoptosis in human pancreatic cancer cells. Co-author DOI 10.1097/cad.0000000000000914↗
  3. Natural Compound Methyl Protodioscin Suppresses Proliferation and Inhibits Glycolysis in Pancreatic Cancer. Co-author DOI 10.1155/2018/7343090↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunfang Xu · 1 shared paper, 2020 · strength 0.19
  2. Zhen Weng · 1 shared paper, 2020 · strength 0.19
  3. Cheng Hang · 1 shared paper, 2022 · strength 0.15
  4. Jianxin Zhu · 1 shared paper, 2022 · strength 0.15
  5. Gong Chen · 1 shared paper, 2022 · strength 0.15
  6. Ye Lu · 1 shared paper, 2022 · strength 0.15
  7. Huifeng Gao · 1 shared paper, 2018 · strength 0.07
  8. Hao Chen · 1 shared paper, 2018 · strength 0.07
  9. Fengjiao Wang · 1 shared paper, 2018 · strength 0.07
  10. Zhen Chen · 1 shared paper, 2018 · strength 0.07
  11. Chao Qu · 1 shared paper, 2018 · strength 0.07
  12. Zhiqiang Meng · 1 shared paper, 2018 · strength 0.07
  13. Lianyu Chen · 1 shared paper, 2018 · strength 0.07
  14. Chien‐shan Cheng · 1 shared paper, 2018 · strength 0.07
  15. Luming Liu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.